Development of poly(anhydride) nanoparticles loaded with peanut proteins: The influence of preparation method on the immunogenic properties

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 82, Issue 2, 2012, Pages 241-249

  Rebouças, Juliana De Souza ^a   Irache, Juan Manuel ^a   Camacho, Ana I ^a   Esparza, Irene ^a   Del Pozo, Victoria ^b   Sanz, María L ^c   Ferrer, Marta ^c   Gamazo, Carlos ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b 28400 Madrid   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Adjuvant; Allergen delivery system; Allergy; Nanoparticles

Indexed keywords

ALCOHOL; FOOD ALLERGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; NANOCARRIER; PEANUT PROTEIN; POLYANHYDRIDE; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DELIVERY SYSTEM; ENCAPSULATION; FREEZE DRYING; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOTHERAPY; MOUSE; NONHUMAN; PARTICLE SIZE; PEANUT ALLERGY; SPRAY DRYING; ZETA POTENTIAL;

ADJUVANTS, IMMUNOLOGIC; ALLERGENS; ANHYDRIDES; ANIMALS; ARACHIS HYPOGAEA; CHEMISTRY, PHARMACEUTICAL; DESENSITIZATION, IMMUNOLOGIC; DRUG DELIVERY SYSTEMS; FEMALE; FREEZE DRYING; IMMUNIZATION; IMMUNOGLOBULIN E; MICE; MICE, INBRED C57BL; NANOPARTICLES; PLANT PROTEINS; POLYMERS;

EID: 84867881147     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.06.014     Document Type: Article

References (51)

1. D.J. Martino, and S.L. Prescott Silent mysteries: epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease Allergy 65 2010 7 15
2. M. Vetander, D. Helander, C. Flodström, E. Ostblom, T. Alfvén, D.H. Ly, G. Hedlin, G. Lilja, C. Nilsson, and M. Wickman Anaphylaxis and reactions to foods in children - a population-based case study of emergency department visits Clin. Exp. Allergy 42 2012 568 577
3. N.U. Nguyen-Luu, M. Ben-Shoshan, R. Alizadehfar, L. Joseph, L. Harada, M. Allen, Y. St.-Pierre, and A. Clark Inadvertent exposures in children with peanut allergy Pediatr. Allergy Immunol. 23 2012 133 139
4. J.O. Hourihane, R. Aiken, R. Briggs, L.A. Gudgeon, K.E. Grimshaw, A. DunnGalvin, and S.R. Robert The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry J. Allergy Clin. Immunol. 119 2007 1197 1202 (Pubitemid 46654178)
5. M. Ben-Shoshan, D.W. Harrington, L. Soller, J. Fragapane, L. Joseph, Y. St.-Pierre, S.B. Godefroy, S.J. Elliot, and A.E. Clarke A population-based study on peanut, tree nut, fish, shellfish, and sesame allergy prevalence in Canada J. Allergy Clin. Immunol. 125 2010 1327 1335
6. S.H. Sicherer, A. Muñoz-Furlong, J.H. Godbold, and H.A. Sampson US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up J. Allergy Clin. Immunol. 125 2010 1322 1326
7. M.B. Soyka, D. Holzmann, and C.A. Akdis Regulatory cells in allergen-specific immunotherapy Immunotherapy 4 2012 389 396
8. J.J. Oppenheimer, H.S. Nelson, S.A. Bock, F. Christensen, and D.Y.M. Leung Treatment of peanut allergy with rush immunotherapy J. Allergy Clin. Immunol. 90 1992 256 262
9. J.M. Rolland, L.M. Gardner, and R.E. O'Hehir Allergen-related approaches to immunotherapy Pharmacol. Ther. 121 2009 273 284
10. A.J. Frew Allergen immunotherapy J. Allergy Clin. Immunol. 125 2010 306 313
11. L. O'Mahony, M. Akdis, R. Crameri, and C.A. Akdis Novel immunotherapeutic approaches for allergy and asthma Autoimmunity 43 2010 493 503
12. T. Schöll, G. Boltz-Nitulescu, and E. Jensen-Jarolim Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy J. Control. Release 104 2005 1 27 (Pubitemid 40615232)
13. T. Schöll, B. Kopp, B. Bohle, and E. Jensen-Jarolim Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy Immunol. Allergy Clin. North Am. 26 2006 349 364
14. S. Broos, K. Lundberg, T. Akagi, K. Kadowaki, M. Akashi, L. Greiff, C.A. Borrebaeck, and M. Lindstedt Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: implications for specific immunotherapy Vaccine 28 2010 5075 5085
15. P. Arbós, M. Wirth, M.A. Arangoa, F. Gabor, and J.M. Irache Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates J. Control. Release 83 2002 321 330 (Pubitemid 35223255)
16. H.H. Salman, C. Gamazo, M.A. Campanero, and J.M. Irache Salmonella-like bioadhesive nanoparticles J. Control. Release 106 2005 1 13 (Pubitemid 41140076)
17. J. Ochoa, J.M. Irache, I. Tamayo, A. Walz, V.G. Del Vecchio, and C. Gamazo Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice Vaccine 25 2007 4410 4419 (Pubitemid 46678567)
18. R. Da Costa Martins, J.M. Irache, J.M. Blasco, M.P. Muñoz, C.M. Marín, M. Grilló, M. Barberán, and C. Gamazo Evaluation of particulate acellular vaccines against Brucella ovis infection in rams Vaccine 28 2010 3038 3046
19. S. Gómez, C. Gamazo, B.S. Roman, C. Vauthier, M. Ferrer, and J.M. Irache Development of a novel vaccine delivery system based on Gantrez nanoparticles J. Nanosci. Nanotechnol. 6 2006 3283 3289 (Pubitemid 44580012)
20. S. Gómez, C. Gamazo, B.S. Roman, M. Ferrer, M.L. Sanz, and J.M. Irache Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens Vaccine 25 2007 5263 5271 (Pubitemid 46977542)
21. S. Gómez, C. Gamazo, B. San Román, A. Grau, S. Espuelas, M. Ferrer, M.L. Sanz, and J.M. Irache A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne J. Immunol. Methods 348 2009 1 8
22. A.S. Porfire, V. Zabaleta, C. Gamazo, S.E. Leucuta, and J.M. Irache Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles Int. J. Pharm. 390 2010 37 44
23. P. Arbós, M.A. Campanero, M.A. Arangoa, M.J. Renedo, and J.M. Irache Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties J. Control. Release 89 2003 19 30 (Pubitemid 36412111)
24. K. Yoncheva, S. Gómez, M.A. Campanero, C. Gamazo, and J.M. Irache Bioadhesive properties of pegylated nanoparticles Expert Opin. Drug Deliv. 2 2005 205 218 (Pubitemid 41130878)
25. A.I. Camacho, R. Da Costa Martins, I. Tamayo, J. de Souza, J.J. Lasarte, C. Mansilla, I. Esparza, J.M. Irache, and C. Gamazo Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators Vaccine 29 2011 7130 7135
26. I. Tamayo, J.M. Irache, C. Mansilla, J. Ochoa-Repáraz, J.J. Lasarte, and C. Gamazo Poly (anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation Clin. Vaccine Immunol. 17 2010 1356 1362
27. P. Ojer, H. Salman, R. Da Costa Martins, J. Calvo, A. López de Cerain, C. Gamazo, J.L. Lavandera, and J.M. Irache Spray-drying of poly(anhydride) nanoparticles for drug/antigen delivery J. Drug Del. Sci. Technol. 20 2010 353 359
28. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk Measurement of protein using bicinchoninic acid Anal. Biochem. 150 1985 76 85 (Pubitemid 16258399)
29. J. Bousquet, R. Lockey, and H.J. Malling Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper J. Allergy Clin. Immunol. 102 1998 558 562
30. A.W. Wheeler, and S.R. Woroniecki Immunological adjuvants in allergy vaccines: past, present and future Allergol. Int. 50 2001 295 301 (Pubitemid 33123386)
31. Y. Perrie, A.R. Mohammed, D.J. Kirby, S.E. McNeil, and V.W. Bramwell Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens Int. J. Pharm. 364 2008 272 280
32. A. des Rieux, V. Fievez, M. Garinot, Y.J. Schneider, and V. Préat Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach J. Control. Release 116 2006 1 27 (Pubitemid 44792295)
33. J. Francis, and S.R. Durham Adjuvants for allergen immunotherapy: experimental results and clinical perspectives Curr. Opin. Allergy Clin. Immunol. 4 2004 543 548 (Pubitemid 39573730)
34. G.P. Li, Z.G. Liu, B. Liao, and N.S. Zhong Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice Cell. Mol. Immunol. 6 2009 45 50
35. J. De Souza Rebouças, I. Esparza, M. Ferrer, M.L. Sanz, J.M. Irache, and C. Gamazo Nanoparticulate adjuvants and delivery systems for allergen immunotherapy J. Biomed. Biotech. 2012 474605
36. S. Espuelas, J.M. Irache, and C. Gamazo Synthetic particulate antigen delivery systems for vaccination Inmunología 24 2005 207 223
37. M.P. Desai, V. Labhasetwar, G.L. Amidon, and R.J. Levy Gastrointestinal uptake of biodegradable microparticles: effect of particle size Pharm. Res. 13 1996 1838 1845 (Pubitemid 27034116)
38. T. Schöll, A. Weissenböck, E. Förster-Waldl, E. Untersmayr, F. Walter, M. Willheim, G. Boltz-Nitulescu, O. Scheiner, F. Gabor, and E. Jensen-Jarolim Allergen-loaded biodegradable poly(d,l-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model Clin. Exp. Allergy 34 2004 315 321 (Pubitemid 38315270)
39. B.S. Roman, S. Espuelas, S. Gómez, C. Gamazo, M.L. Sanz, M. Ferrer, and J.M. Irache Intradermal immunization with ovalbumin-loaded poly-epsilon-caprolactone microparticles conferred protection in ovalbumin-sensitized allergic mice Clin. Exp. Allergy 37 2007 287 295 (Pubitemid 46148287)
40. O. Palomares, G. Yaman, A.K. Azkur, T. Akkoc, M. Akdis, and C.A. Akdis Role of Treg in immune regulation of allergic diseases Eur. J. Immunol. 40 5 2010 1232 1240
41. K. Oboki, T. Ohno, H. Saito, and S. Nakae TH17 and allergy Allergol. Int. 57 2 2008 121 134 (Pubitemid 351897666)
42. W.G. Degen, T. Jansen, and V.E. Schijns Vaccine adjuvant technology: from mechanistic concepts to practical applications Expert Rev. Vaccines 2 2003 327 335 (Pubitemid 36559933)
43. Y. Tabata, Y. Inoue, and Y. Ikada Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres Vaccine 14 1996 1677 1685 (Pubitemid 27041922)
44. I. Gutierro, R.M. Hernandez, M. Igartua, A.R. Gascon, and J.L. Pedraz Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres Vaccine 21 2002 67 77 (Pubitemid 35351352)
45. K.Y. Win, and S.S. Feng Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs Biomaterials 26 2005 2713 2722
46. T. Jung, W. Kamma, A. Breitenbach, E. Kaiserling, J.X. Xiao, and T. Kissel Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur. J. Pharm. Biopharm. 50 2000 147 160 (Pubitemid 30326694)
47. H.H. Salman, J.M. Irache, and C. Gamazo Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination Vaccine 27 2009 4784 4790
48. M.A. Dobrovolskaia, P. Aggarwal, J.B. Hall, and S.E. McNeil Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution Mol. Pharm. 5 2008 487 495
49. A.E. Nel T-cell activation through the antigen receptor. Part 1: Signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse J. Allergy Clin. Immunol. 109 2002 758 770 (Pubitemid 34499506)
50. J. Zhu, and W.E. Paul Heterogeneity and plasticity of T helper cells Cell Res. 20 2010 4 12
51. X. Tao, S. Constant, P. Jorritsma, and K. Bottomly Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation J. Immunol. 159 1997 5956